Genetic and phenotypic characterisation of Escherichia coli producing cefotaximase-type extended-spectrum β-lactamases: first evidence of the ST131 clone in cats with urinary infections in Italy

Journal of Feline Medicine and Surgery

Volumn 16, Issue 12, 2014, Pages 966-971

  Nebbia, Patrizia ^a   Tramuta, Clara ^a   Odore, Rosangela ^a   Nucera, Daniele ^a   Zanatta, Renato ^a   Robino, Patrizia ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI;

BETA LACTAMASE; BETA-LACTAMASE CTX-M-15;

ANIMAL; CAT; CAT DISEASE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; GENETICS; ISOLATION AND PURIFICATION; ITALY; MALE; METABOLISM; MICROBIOLOGY; MULTIDRUG RESISTANCE; PATHOGENICITY; POLYMERASE CHAIN REACTION; URINARY TRACT INFECTION; VETERINARY;

ANIMALS; BETA-LACTAMASES; CAT DISEASES; CATS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; ITALY; MALE; POLYMERASE CHAIN REACTION; URINARY TRACT INFECTIONS;

EID: 84911883879     PISSN: 1098612X     EISSN: 15322750     Source Type: Journal    
DOI: 10.1177/1098612X14527103     Document Type: Article

References (45)

1. Carattoli A,Lovari S,Franco A, et al.Extended-spectrum beta-lactamases in Escherichia coli isolated from dogs and cats in Rome, Italy, from 2001 to 2003.Antimicrob Agents Chemother. 2005;49:833-835
2. Harada K,Niina A,Nakai Y, et al.Prevalence of antimicrobial resistance in relation to virulence genes and phylogenetic origins among urogenital Escherichia coli isolates from dogs and cats in Japan.Am J Vet Res. 2012;73:409-417
3. Huber H,Zweifel C,Wittenbrink MM, et al.ESBL-producing uropathogenic Escherichia coli isolated from dogs and cats in Switzerland.Vet Microbiol. 2013;162:992-996
4. Ewers C,Grobbel M,Stamm I, et al.Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals.J Antimicrob Chemother. 2010;65:651-660
5. White JD,Stevenson M,Malik R, et al.Urinary tract infections in cats with chronic kidney disease.J Feline Med Surg. 2013;15:459-465
6. Johnson JR,O’Bryan TT,Kuskowski M, et al.Ongoing horizontal and vertical transmission of virulence genes and papA alleles among Escherichia coli blood isolates from patients with diverse-source bacteremia.Infect Immun. 2001;69:5363-5374
7. Belanger L,Garenaux A,Harel J, et al.Escherichia coli from animal reservoirs as a potential source of human extraintestinal pathogenic E coli.Fems Immunol Med Microbiol. 2011;62:1-10
8. Tamang MD,Nam HM,Gurung M, et al.Molecular characterization of CTX-M beta-lactamase and associated addiction systems in Escherichia coli circulating among cattle, farm workers, and the farm environment.Appl Environ Microbiol. 2013;79:3898-3905
9. Pitout JDD,Laupland KB.Extended-spectrum beta-lactamase-producing enterobacteriaceae: an emerging public-health concern.Lancet Infect Dis. 2008;8:159-166
10. Canton R,Coque TM.The CTX-M beta-lactamase pandemic.Curr Opin Microbiol. 2006;9:466-475
11. Peirano G,Pitout JDD.Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4.Int J Antimicrob Agents. 2010;35:316-321
12. Bahrani-Mougeot NWGI,Donnemberg MS,Mobley HLTEscherichia coli. Virulence mechanisms of a versatile pathogen. Donnenberg MS, ed. San Diego: Academic Press; 2002:239-268.
13. Hasman H,Mevius D,Veldman K, et al.beta-Lactamases among extended-spectrum beta-lactamase (ESBL)-resistant Salmonella from poultry, poultry products and human patients in The Netherlands.J Antimicrob Chemother. 2005;56:115-121
14. Jiang XF,Ni YX,Jiang YQ, et al.Outbreak of infection caused by Enterobacter cloacae producing the novel VEB-3 beta-lactamase in China.J Clin Microbiol. 2005;43:826-831
15. Nebbia P,Tramuta C,Giammarino M, et al.Antimicrobial resistance, class 1 and 2 integrons and gene cassettes in avian Escherichia coli.Ital J Anim Sci. 2008;7:391-395
16. Le Bouguenec C,Archambaud M,Labigne A.Rapid and specific detection of the pap, afa, and sfa adhesin-encoding operons in uropathogenic Escherichia coli strains by polymerase chain reaction.J Clin Microbiol. 1992;30:1189-1193
17. Moulin-Schouleur M,Schouler C,Tailliez P, et al.Common virulence factors and genetic relationships between O18:K1:H7 Escherichia coli isolates of human and avian origin.J Clin Microbiol. 2006;44:3484-3492
18. Toth I,Herault F,Beutin L, et al.Production of cytolethal distending toxins by pathogenic Escherichia coli strains isolated from human and animal sources: Establishment of the existence of a new cdt variant (type IV).J Clin Microbiol. 2003;41:4285-4291
19. Pass MA,Odedra R,Batt RM.Multiplex PCRs for identification of Escherichia coli virulence genes.J Clin Microbiol. 2000;38:2001-2004
20. Yamamoto S,Terai A,Yuri K, et al.Detection of urovirulence factors in Escherichia coli by multiplex polymerase chain reaction.FEMS Immunol Med Microbiol. 1995;12:85-90
21. Johnson JR,Stell AL.Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise.J Infect Dis. 2000;181:261-272
22. Johnson JR,Johnston B,Kuskowski MA, et al.Molecular epidemiology and phylogenetic distribution of the Escherichia coli pks genomic island.J Clin Microbiol. 2008;46:3906-3911
23. Clermont O,Bonacorsi S,Bingen E.Rapid and simple determination of the Escherichia coli phylogenetic group.Appl Environ Microbiol. 2000;66:4555-4558
24. Ostblom A,Adlerberth I,Wold AE, et al.Pathogenicity island markers, virulence determinants malX and usp, and the capacity of Escherichia coli to persist in infants’ commensal microbiotas.Appl Environ Microbiol. 2011;77:2303-2308
25. Soto SM,Jimenez de Anta MT,Vila J.Quinolones induce partial or total loss of pathogenicity islands in uropathogenic Escherichia coli by SOS-dependent or -independent pathways, respectively.Antimicrob Agents Chemother. 2006;50:649-653
26. Johnson JR,Kuskowski MA,Gajewski A, et al.Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis.J Infect Dis. 2005;191:46-50
27. Woodford N,Carattoli A,Karisik E, et al.Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.Antimicrob Agents Chemother. 2009;53:4472-4482
28. Woegerbauer M,Zeinzinger J,Springer B, et al.Prevalence of the aminoglycoside phosphotransferase genes aph(3’)-IIIa and aph(3’)-IIa in Escherichia coli, Enterococcus faecalis, Enterococcus faecium, Pseudomonas aeruginosa, Salmonella enterica subsp enterica, and Staphylococcus aureus isolates in Austria.J Med Microbiol. 2014;63:21-17
29. Olesen B,Hansen DS,Nilsson F, et al.Prevalence and characteristics of the epidemic multiresistant Escherichiacoli ST131 clonal group among extended-spectrum beta-lactamase-producing E coli isolates in Copenhagen, Denmark.J Clin Microbiol. 2013;51:1779-1785
30. Owens RC,Johnson JR,Stogsdill P, et al.Community transmission in the United States of a CTX-M-15-producing sequence type ST131 Escherichia coli strain resulting in death.J Clin Microbiol. 2011;49:3406-3408
31. Gibreel TM,Dodgson AR,Cheesbrough J, et al.Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England.J Antimicrob Chemother. 2012;67:346-356
32. Platell JL,Cobbold RN,Johnson JR, et al.Clonal group distribution of fluoroquinolone-resistant Escherichia coli among humans and companion animals in Australia.J Antimicrob Chemother. 2010;65:1936-1938
33. Dierikx CM,Van Duijkeren E,Schoormans AHW, et al.Occurrence and characteristics of extended-spectrum-lactamase- and AmpC-producing clinical isolates derived from companion animals and horses.J Antimicrob Chemother. 2012;67:1368-1374
34. Mora A,Herrera A,Mamani R, et al.Recent emergence of clonal group O25b:K1:H4-B2-ST131 ibeA strains among Escherichia coli poultry isolates, including CTX-M-9-producing strains, and comparison with clinical human isolates.Appl Environ Microbiol. 2010;76:6991-6997
35. Cortes P,Blanc V,Mora A, et al.Isolation and characterization of potentially pathogenic antimicrobial-resistant Escherichia coli strains from chicken and pig farms in Spain.Appl Environ Microbiol. 2010;76:2799-2805
36. Franiek N,Orth D,Grif K, et al.ESBL-producing E coli and EHEC in dogs and cats in the Tyrol as possible source of human infection [article in German].Berl Munch Tierarztl Wochenschr. 2012;125:469-475
37. Borjesson S,Bengtsson B,Jernberg C, et al.Spread of extended-spectrum beta-lactamase producing Escherichia coli isolates in Swedish broilers mediated by an incl plasmid carrying bla (CTX-M-1).Acta Vet Scand. 2013;55:3
38. Giufre M,Graziani C,Accogli M, et al.Escherichia coli of human and avian origin: detection of clonal groups associated with fluoroquinolone and multidrug resistance in Italy.J Antimicrob Chemoth. 2012;67:860-867
39. Zdziarski J,Svanborg C,Wullt B, et al.Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation?.Infect Immun. 2008;76:695-703
40. Wieler LH,Ewers C,Guenther S, et al.Methicillin-resistant staphylococci (MRS) and extended-spectrum beta-lactamases (ESBL)-producing Enterobacteriaceae in companion animals: Nosocomial infections as one reason for the rising prevalence of these potential zoonotic pathogens in clinical samples.Int J Med Microbiol. 2011;301:635-641
41. Barsanti JA3rd ed. Philadelphia: Saunders Elsevier, 2006, pp 935–961.Greene CE, ed. Saunders Elsevier; 2006:935-961.
42. Albarellos GA,Denamiel GA,Montoya L, et al.Pharmacokinetics of imipenem after intravenous, intramuscular and subcutaneous administration to cats.J Feline Med Surg. 2013;15:483-487
43. Guardabassi L,Schwarz S,Lloyd DH.Pet animals as reservoirs of antimicrobial-resistant bacteria.J Antimicrob Chemother. 2004;54:321-332
44. Maaland M,Guardabassi L.In vitro antimicrobial activity of nitrofurantoin against Escherichia coli and Staphylococcus pseudintermedius isolated from dogs and cats.Vet Microbiol. 2011;151:396-399
45. Gerber B,Boretti FS,Kley S, et al.Evaluation of clinical signs and causes of lower urinary tract disease in European cats.J Small Anim Pract. 2005;46:571-577